Is Balchem Corporation (BCPC) Overvalued?
We dive into why Balchem Corporation (BCPC) could be considered overvalued on 2026-07-28, based on AAII’s Value Score and Grade.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Commentary & Analysis
Which Is a Better Investment, Balchem Corporation or Eastman Chemical Company Stock?
Learn more about whether Balchem Corporation or Eastman Chemical Company is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Jenna Brashear
What You Need to Know About Balchem Corporation's Q2 Earnings
Balchem Corporation's fiscal Q2 earnings report was released on Thursday, April 30. Let's dive in to see if (BCPC) missed or beat analyst's expectations.Jenna Brashear
What You Need to Know About Balchem Corporation's Q1 Earnings
Balchem Corporation's fiscal Q1 earnings report was released on Friday, February 20. Let's dive in to see if (BCPC) missed or beat analyst's expectations.Jenna Brashear
Why Balchem Corporation’s (BCPC) Stock Is Up 5.28%
As of Thursday, December 11, Balchem Corporation’s BCPC share price has surged by 5.28%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | BCPC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5,228.5 | $3,782.4 | 68% |
|
| Shares Out (Mil) | 32.3 | 85.1 | 38% |
|
| Institutional Ownership | 99.4% | 87.2% | 88% |
|
| Float (Mil) | 31.9 | 118.1 | 38% |
|
| Beta | 0.83 | 0.81 | 49% |
|
| Avg Daily Volume (000s) | 178 | 172 | 43% |
|
| Price Change (52-week) |
6.5% | 82.0% | 51% |
|
| Growth | BCPC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.1% | 4.2% | 51% |
|
| Net Income (5yr) | 12.8% | 1.2% | 59% |
|
| EPS (5yr) | 12.8% | 3.1% | 51 |
|
| Dividends (5yr) | 10.6% | 0.0% | 78% |
|
| Cash Flow (5yr) | 5.7% | (15.3%) | 68% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 3 | 3 | |
| Current EPS | $1.425 | $5.685 | $6.110 | |
| Month Ago EPS | $1.425 | $5.685 | $6.110 | |
| # Rev Up | 1 | 1 | 3 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $1.405 | $5.686 | $6.074 | |
| Year/Year Chg | 14.0% | 19.7% | 47.0% | |
| Financials | BCPC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,057 | $4,050 | 51% |
|
| Net Income (TTM) (Mil) | $158 | $53 | 66% |
|
| EPS (TTM) | $4.919 | $0.300 | 87% |
|
| Operating Cash Flow (TTM) (Mil) | $220 | $388 | 61% |
|
| Net Cash Flow (TTM) (Mil) | $23 | $6 | 64% |
|
| Long-Term Debt (Q1) (Mil) | $181 | $1,738 | 49% |
|
| Enterprise Value (Q1) (Mil) | $5,371 | $5,563 | 64% |
|
| Valuation | BCPC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.07 | 1.46 | 73% |
|
| P/E | 33.4 | 24.6 | 72% |
|
| Dividend Yield | 0.6% | 1.3% | 63% |
|
| PEG (5yr hist) | 2.6 | 2.1 | 75% |
|
| Ratios | BCPC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 36.3% | 29.4% | 44% |
|
| Net Margin | 15.0% | 3.0% | 73% |
|
| ROA | 9.5% | 1.7% | 86% |
|
| ROE | 12.7% | 4.4% | 66% |
|
| Liabilities to Assets | 24.1% | 53.5% | 16% |
|
| F-Score | 9 | 5 | 99% |
|
Balchem Corporation did not pass any screens on 7/30/2026.
